Status:
COMPLETED
A Study of the Long-Term Outcomes of HIV-Positive Patients
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infections
Eligibility:
All Genders
13+ years
Brief Summary
The purpose of this study is to collect information about life spans and HIV-related illnesses in multiple groups of HIV-positive patients with varying anti-HIV treatment experience, including no trea...
Detailed Description
Highly active antiretroviral therapy (HAART) often results in short-term benefits for people with HIV in terms of reduced plasma viral levels and increased CD4 cell counts. When used at an early stage...
Eligibility Criteria
Inclusion Criteria
Patients may be eligible for this study if they:
- Are 13 years of age or older (consent of parent or guardian required if under the age of 18).
- Are HIV-positive.
- Have either: (1) no previous experience with anti-HIV treatment (defined as no previous protease inhibitor or nonnucleoside reverse transcriptase inhibitor use, 1 week or less of lamivudine use, and 4 weeks or less of cumulative nucleoside reverse transcriptase inhibitor use) or (2) current or previous enrollment in a qualifying CPCRA study.
Key Trial Info
Start Date :
March 1 1999
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
3669 Patients enrolled
Trial Details
Trial ID
NCT00000932
Start Date
March 1 1999
End Date
September 1 2006
Last Update
April 15 2014
Active Locations (91)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. M. Estes Med. Practice CRS
Mill Valley, California, United States, 94941-3013
2
Dr. Robert Scott Med. Practice CRS
Oakland, California, United States, 94609
3
East Bay AIDS Ctr. CRS
Oakland, California, United States, 94609
4
Dr. Shawn Hassler Med. Practice CRS
San Francisco, California, United States, 94102